S&P 500   4,266.40 (-0.50%)
DOW   33,317.12 (-0.57%)
QQQ   359.69 (+0.40%)
AAPL   173.11 (+1.11%)
MSFT   319.42 (+1.16%)
META   304.30 (+1.36%)
GOOGL   133.27 (+1.84%)
AMZN   128.95 (+1.44%)
TSLA   249.08 (-0.46%)
NVDA   445.68 (+2.46%)
NIO   8.76 (-3.10%)
BABA   86.20 (-0.62%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.49 (-0.79%)
CGC   0.74 (-5.75%)
GE   108.58 (-1.78%)
DIS   81.37 (+0.39%)
AMC   8.09 (+1.25%)
PFE   33.75 (+1.75%)
PYPL   58.57 (+0.19%)
NFLX   380.01 (+0.64%)
S&P 500   4,266.40 (-0.50%)
DOW   33,317.12 (-0.57%)
QQQ   359.69 (+0.40%)
AAPL   173.11 (+1.11%)
MSFT   319.42 (+1.16%)
META   304.30 (+1.36%)
GOOGL   133.27 (+1.84%)
AMZN   128.95 (+1.44%)
TSLA   249.08 (-0.46%)
NVDA   445.68 (+2.46%)
NIO   8.76 (-3.10%)
BABA   86.20 (-0.62%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.49 (-0.79%)
CGC   0.74 (-5.75%)
GE   108.58 (-1.78%)
DIS   81.37 (+0.39%)
AMC   8.09 (+1.25%)
PFE   33.75 (+1.75%)
PYPL   58.57 (+0.19%)
NFLX   380.01 (+0.64%)
S&P 500   4,266.40 (-0.50%)
DOW   33,317.12 (-0.57%)
QQQ   359.69 (+0.40%)
AAPL   173.11 (+1.11%)
MSFT   319.42 (+1.16%)
META   304.30 (+1.36%)
GOOGL   133.27 (+1.84%)
AMZN   128.95 (+1.44%)
TSLA   249.08 (-0.46%)
NVDA   445.68 (+2.46%)
NIO   8.76 (-3.10%)
BABA   86.20 (-0.62%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.49 (-0.79%)
CGC   0.74 (-5.75%)
GE   108.58 (-1.78%)
DIS   81.37 (+0.39%)
AMC   8.09 (+1.25%)
PFE   33.75 (+1.75%)
PYPL   58.57 (+0.19%)
NFLX   380.01 (+0.64%)
S&P 500   4,266.40 (-0.50%)
DOW   33,317.12 (-0.57%)
QQQ   359.69 (+0.40%)
AAPL   173.11 (+1.11%)
MSFT   319.42 (+1.16%)
META   304.30 (+1.36%)
GOOGL   133.27 (+1.84%)
AMZN   128.95 (+1.44%)
TSLA   249.08 (-0.46%)
NVDA   445.68 (+2.46%)
NIO   8.76 (-3.10%)
BABA   86.20 (-0.62%)
AMD   102.41 (-0.40%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.49 (-0.79%)
CGC   0.74 (-5.75%)
GE   108.58 (-1.78%)
DIS   81.37 (+0.39%)
AMC   8.09 (+1.25%)
PFE   33.75 (+1.75%)
PYPL   58.57 (+0.19%)
NFLX   380.01 (+0.64%)
NYSE:MRK

Merck & Co., Inc. (MRK) Earnings Date, Estimates & Call Transcripts

$101.93
-1.02 (-0.99%)
(As of 02:22 PM ET)
Compare
Today's Range
$101.35
▼
$102.83
50-Day Range
$102.95
▼
$111.34
52-Week Range
$86.02
▼
$119.65
Volume
3.86 million shs
Average Volume
7.53 million shs
Market Capitalization
$258.65 billion
P/E Ratio
83.55
Dividend Yield
2.86%
Price Target
$124.74
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Oct. 26
Before Market Opens
Confirmed
Actual EPS
(Aug. 1)
-$2.06 Beat By $0.12
Consensus EPS
(Aug. 1)
-$2.18
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MRK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Merck & Co., Inc. Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$1.33$1.55$1.45 
Q2 20233($2.24)$1.88$0.48 
Q3 20234($1.46)$1.90$1.02 
Q4 20234$1.71$1.92$1.83 
FY 202314($0.66)$7.25$4.77 
Q1 20243$1.80$1.90$1.86 
Q2 20243$1.88$2.02$1.96 
Q3 20243$2.05$2.13$2.09 
Q4 20243$2.12$2.19$2.16 
FY 202412$7.85$8.24$8.07 
Q1 20251$2.32$2.32$2.32 
Q2 20251$2.35$2.35$2.35 

MRK Earnings Date and Information

Merck & Co., Inc. last issued its quarterly earnings data on August 1st, 2023. The reported ($2.06) earnings per share for the quarter, topping the consensus estimate of ($2.18) by $0.12. The company had revenue of $15.04 billion for the quarter, compared to analyst estimates of $14.44 billion. Its quarterly revenue was up 3.0% on a year-over-year basis. Merck & Co., Inc. has generated $1.22 earnings per share over the last year ($1.22 diluted earnings per share) and currently has a price-to-earnings ratio of 83.9. Earnings for Merck & Co., Inc. are expected to grow by 180.86% in the coming year, from $3.03 to $8.51 per share. Merck & Co., Inc. has confirmed that its next quarterly earnings report will be published on Thursday, October 26th, 2023. Merck & Co., Inc. will be holding an earnings conference call on Thursday, October 26th at 9:00 AM Eastern. Interested parties can register for or listen to the call..

Merck & Co., Inc. Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/26/2023
Confirmed)		-------  
8/1/2023Q2 2023($2.18)($2.06)+$0.12($1.77)$14.44 billion$15.04 billion    
4/27/2023Q1 2023$1.34$1.40+$0.06$1.69$13.81 billion$14.49 billion    
2/2/2023Q4 2022$1.56$1.62+$0.06$2.06$13.66 billion$13.83 billion    
10/27/2022Q3 2022$1.67$1.85+$0.18$2.42$14.05 billion$14.96 billion    
7/28/2022Q2 2022$1.67$1.87+$0.20$2.19$13.85 billion$14.59 billion    
4/28/2022Q1 2022$1.81$2.14+$0.33$2.58$14.64 billion$15.90 billion    
2/3/2022Q4 2021$1.46$1.80+$0.34$2.12$13.14 billion$13.25 billion    
10/27/2021Q3 2021$1.55$1.75+$0.20$1.70$12.32 billion$13.15 billion    
7/28/2021Q2 2021$1.31$1.31-$2.01$11.21 billion$11.40 billion    
4/29/2021Q1 2021$1.63$1.40($0.23)$1.55$12.71 billion$12.08 billion  
2/3/2021Q4 2020$1.38$1.32($0.06)$3.47$12.65 billion$12.51 billion  
10/27/2020Q3 2020$1.44$1.74+$0.30$2.32$12.21 billion$12.55 billion  












Merck & Co., Inc. Earnings - Frequently Asked Questions

When is Merck & Co., Inc.'s earnings date?

Merck & Co., Inc. has confirmed that its next quarterly earnings data will be published on Thursday, October 26th, 2023. Learn more on MRK's earnings history.

Did Merck & Co., Inc. beat their earnings estimates last quarter?

In the previous quarter, Merck & Co., Inc. (NYSE:MRK) reported ($2.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.18) by $0.12. Learn more on analysts' earnings estimate vs. MRK's actual earnings.

How can I listen to Merck & Co., Inc.'s earnings conference call?

The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online. Listen to Conference Call

How can I read Merck & Co., Inc.'s conference call transcript?

The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online. Read Transcript

How much revenue does Merck & Co., Inc. generate each year?

Merck & Co., Inc. (NYSE:MRK) has a recorded annual revenue of $59.28 billion.

How much profit does Merck & Co., Inc. generate each year?

Merck & Co., Inc. (NYSE:MRK) has a recorded net income of $14.52 billion. MRK has generated $1.22 earnings per share over the last four quarters.

What is Merck & Co., Inc.'s price-to-earnings ratio?

Merck & Co., Inc. (NYSE:MRK) has a trailing price-to-earnings ratio of 83.85 and a forward price-to-earnings ratio of 33.76. The price/earnings-to-growth ratio is 4.06.

What is Merck & Co., Inc.'s EPS forecast for next year?

Merck & Co., Inc.'s earnings are expected to grow from $3.03 per share to $8.51 per share in the next year, which is a 180.86% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:MRK) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -